Skip to content

Effect of Nigella sativa oil in patients with polycystic ovary

The effect of nigella sativa oil on serum levels of Total antioxidant capacity(TAOC) and Malondialdehyde(MDA) in patients with polycystic ovarian syndrome

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231124060163N1
Enrollment
60
Registered
2023-12-06
Start date
2023-12-21
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group:subjects receiving black seed oil,In this group,subgects will receive capsules containing black seed oil with a dose of1000 mg per day orally for three months.Black

Sponsors

Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Oligomenorrhea or lack of ovlation polycystic ovaries based on ultrasound Androgenic hormone changes in laboratory or clinical form (the presence of hirsutism)

Exclusion criteria

Exclusion criteria: Type 2 diabets Thyroid disease Adernal hyperplasia Autoimmune disease Hyperprolactinemia People with structured physical activity or scheduled exercise If three months before entering the study,they use a special diet or special drugs that may affect the results ,they will be excluded from the study ,such as anti-obesity drugs,induction ovulation,antidepressants,insulin sensivity,oral contraceotives,asprin,and anti-prostaglandin drugs If there are signs of pregnancy,they will be excludedfrom the study

Design outcomes

Primary

MeasureTime frame
Malondialdehyde(MDA). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Total antioxidant capacity(TAOC). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.

Secondary

MeasureTime frame
Triglyceride. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Cholesterol. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;High-density lipoprotein (HDL). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Low-density lipoprotein (LDL). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSHahla Farzipour

Ardabil University of Medical Sciences

shahla.farzipour@gmail.com+98 45 3324 8888

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026